IMMUNITYBIO INC
(NASDAQ: IBRX)

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

7.650

-0.100 (-1.29%)
Range 7.540 - 8.068   (7%)
Open 7.770
Previous Close 7.750
Bid Price 2.790
Bid Volume 32
Ask Price 2.820
Ask Volume 8
Volume 4,922,791
Value -
Remark
Delayed prices. Updated at 18 May 2024 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis